| 6032 |
Centers for Disease Control and Prevention |
Html |
en |
o-Chlorotoluene - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6381 |
Centers for Disease Control and Prevention |
Html |
en |
Asthma - Basic Information |
Asthma - Learn How to Control Asthma |
| cockroach allergen | 0.47819 |
| mouthpiece | 0.417226 |
| milder attacks | 0.472622 |
| certain times | 0.478429 |
| tree trunk | 0.475865 |
| children | 0.43439 |
| lungs | 0.617849 |
| doctor check | 0.481633 |
| checkup | 0.420046 |
| common triggers | 0.48921 |
| asthma attacks | 0.702303 |
| tobacco smoke | 0.468875 |
| dust mites | 0.473023 |
| night | 0.434108 |
| airflow | 0.416719 |
| colds | 0.417438 |
| asthma | 0.989547 |
| asthma attack | 0.839667 |
| symptoms | 0.428524 |
| effects | 0.440194 |
| spirometry | 0.420089 |
| Asthma medicines | 0.736226 |
| body’s airways | 0.491069 |
| clogs | 0.417091 |
| long-term control | 0.600364 |
|
| Long-term control medicines | 0.563556 |
| Asthma Inhaler | 0.662284 |
| long-term control medicine | 0.532191 |
| breathing problems | 0.54693 |
| allergies | 0.434085 |
| asthma triggers | 0.677982 |
| different medicine | 0.466644 |
| outdoor air pollution | 0.530409 |
| trouble breathing | 0.483649 |
| burning wood | 0.473235 |
| chest tightness | 0.689971 |
| common long-term diseases | 0.5621 |
| deep breath | 0.479077 |
| warning signs | 0.475356 |
| cases | 0.41734 |
| bothers | 0.420949 |
| breathing test | 0.483377 |
| asthma action plan | 0.711381 |
| physical activity | 0.48182 |
| doctor | 0.601201 |
| healthcare provider | 0.47407 |
| quick-relief medicines | 0.550014 |
| family | 0.433093 |
| lungs work | 0.527986 |
|
CLICK HERE |
| 7597 |
Centers for Disease Control and Prevention |
Html |
en |
TB - Infection Control and Prevention |
Centers for Disease Control and Prevention, Division of Tuberculosis Elimination |
| infectious TB disease | 0.539687 |
| three-level hierarchy | 0.304873 |
| TB infection-control plan | 0.569979 |
| management measures | 0.291662 |
| local exhaust ventilation | 0.334452 |
| TB infection-control data | 0.552634 |
| airborne infection isolation | 0.363196 |
| TB risk assessment | 0.581991 |
| infection control program | 0.529755 |
| state health departments | 0.346911 |
| respiratory hygiene | 0.360707 |
| infection control plan | 0.412895 |
| health care setting | 0.370405 |
| important level | 0.282623 |
| Administrative controls | 0.280789 |
| personal protective equipment | 0.329743 |
| patients | 0.279444 |
| proper cleaning | 0.276773 |
| TB control | 0.544862 |
| exposure | 0.307412 |
| health care settings | 0.62263 |
| high risk | 0.351638 |
| infectious TB | 0.566143 |
| TB infection control | 0.907454 |
|
| recommended laboratory processing | 0.346963 |
| ultraviolet germicidal irradiation | 0.342711 |
| effective work practices | 0.344804 |
| TB disease | 0.897609 |
| cough etiquette | 0.356193 |
| health care workers | 0.697026 |
| respiratory protection | 0.390501 |
| high-risk health-care | 0.279736 |
| health care | 0.808784 |
| general infection control | 0.41261 |
| higher risk | 0.29931 |
| following activities | 0.284258 |
| respiratory protection program | 0.355294 |
| Primary environmental controls | 0.339269 |
| infectious droplet nuclei | 0.45966 |
| Secondary environmental controls | 0.334696 |
| epidemiology-based prevention principles | 0.342061 |
| cough etiquette procedures | 0.338378 |
| respiratory protection equipment | 0.350122 |
| following measures | 0.279458 |
| control measures | 0.304159 |
| environmental controls | 0.375619 |
| respiratory-protection control | 0.282887 |
| congregate settings | 0.285858 |
|
CLICK HERE |
| 7995 |
Centers for Disease Control and Prevention |
Html |
es |
CDC - Preventing Chronic Disease: Volume 9, 2012: 12_0136 |
Volumen 9 — Diciembre 27, 2012. |
| Campbell VA | 0.472876 |
| salud pública | 0.696043 |
| Estados Unidos | 0.815009 |
| Armour BS | 0.510092 |
|
| Chronic Dis | 0.490715 |
| Courtney-Long E | 0.486397 |
| Wethington HR | 0.494723 |
|
CLICK HERE |
| 8270 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: School Reporting of a Dengue Outbreak- St. Croix, U.S. Virgin Islands, 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.51251 |
| reliable baseline case | 0.572241 |
| index school | 0.505832 |
| Human Services | 0.549213 |
| assistive technology | 0.502778 |
| MMWR HTML versions | 0.558415 |
| U.S. Department | 0.547722 |
| viremic students | 0.497948 |
| DENV infection | 0.497438 |
| IgM anti-DENV | 0.691531 |
| school nurse | 0.503368 |
| electronic PDF version | 0.558734 |
| Zoonotic Infectious Diseases | 0.72379 |
| Darice Plaskett | 0.498618 |
| dengue cases | 0.748693 |
| recent dengue virus | 0.835588 |
| stratified two-stage cluster | 0.578481 |
| National Center | 0.573937 |
| Virgin Islands | 0.754981 |
| diagnostic testing | 0.497347 |
| Virgin Islands Department | 0.594022 |
| Aedes aegypti mosquitoes | 0.605334 |
| immature mosquitoes | 0.606276 |
| original paper copy | 0.552149 |
|
| common regional source | 0.560265 |
| Vector-Borne Diseases | 0.653334 |
| additional schools | 0.511327 |
| islandwide dengue outbreak | 0.826216 |
| United States | 0.551423 |
| U.S. Government Printing | 0.565815 |
| original MMWR paper | 0.564837 |
| St. Croix | 0.666724 |
| CDC Dengue Branch | 0.983598 |
| personal protective measures | 0.55138 |
| Esther Ellis | 0.551438 |
| current infection | 0.499676 |
| U.S. Virgin Islands | 0.740893 |
| dengue surveillance | 0.73128 |
| passive dengue reporting | 0.844277 |
| school staff members | 0.579838 |
| subject line | 0.503715 |
| staff members | 0.683954 |
| seroincidence study | 0.495909 |
| school reporting | 0.501747 |
| Dana Thomas | 0.547873 |
| A. aegypti | 0.50206 |
| study schools | 0.512 |
| bites.* Health-care personnel | 0.561129 |
|
CLICK HERE |
| 10449 |
Centers for Disease Control and Prevention |
Html |
en |
Conference Call October 16, 2012'Clinicians Outreach and Communication Activity (COCA) |
CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 11390 |
Centers for Disease Control and Prevention |
Html |
en |
Guidance for Safe Handling of Human Remains of Ebola Patients in U. S. Hospitals and Mortuaries |
null |
| postmortem care | 0.271554 |
| CDC | 0.232497 |
| PPE | 0.328592 |
| postmortem care settings | 0.242785 |
| Ebola website | 0.203589 |
| thermal sealer | 0.243858 |
| EPA-registered hospital | 0.261703 |
| U.S. Environmental Protection | 0.216677 |
| biohazard spill kit | 0.211294 |
| hospital disinfectant | 0.264158 |
| ebola virus | 0.465732 |
| electronic medical devices | 0.319734 |
| biohazard waste bags | 0.208248 |
| heat-sealed bag | 0.220158 |
| leakproof body bag | 0.341153 |
| final disposition | 0.228878 |
| standard metal casket | 0.213767 |
| postmortem preparation | 0.314351 |
| hospital | 0.37126 |
|
| workers | 0.325767 |
| Guidance Job Aid | 0.238851 |
| hot zone | 0.619001 |
| personal protective equipment | 0.615107 |
| EPA-registered disinfectant wipe | 0.248847 |
| step-by-step guidelines | 0.243347 |
| bag material | 0.229563 |
| body bag | 0.993394 |
| human remains | 0.528938 |
| Red biohazard bag | 0.269916 |
| comparable burial method | 0.209849 |
| cold zone | 0.556514 |
| Mortuary Guidance Job | 0.248562 |
| healthcare workers | 0.318971 |
| mobile phone | 0.213884 |
| gurney | 0.226157 |
| Environmental Protection Agency | 0.219853 |
| long-sleeved disposable gown | 0.316748 |
|
CLICK HERE |
| 13048 |
Centers for Disease Control and Prevention |
Html |
es |
No permita que el sarampión sea su recuerdo de viaje |
Manténgase sano y salvo cuando viaje al extranjero. El sarampión se transmite fácilmente a través de la tos y los estornudos. Puede causar enfermedad grave e incluso la muerte. Asegúrese de que usted y su familia estén vacunados contra el sarampión antes viajar. |
| Archivo Apple Quicktime | 0.416973 |
| vacuna mmr | 0.906846 |
| familia estén | 0.583458 |
| Archivo Zip Comprimido | 0.415179 |
| Archivo Microsoft PowerPoint | 0.426569 |
|
| Archivo Adobe PDF | 0.416558 |
| Archivo Microsoft Excel | 0.415684 |
| Estados Unidos | 0.76355 |
| Archivo Microsoft | 0.627678 |
|
CLICK HERE |
| 13334 |
Centers for Disease Control and Prevention |
Html |
en |
Vital Signs: Melanoma Incidence and Mortality Trends andProjections - United States, 1982-2030 |
On June 2, 2015, this report was posted as an MMWR Early Release on the MMWR website (http://www.cdc.gov/mmwr). |
| skin cancer risk | 0.292407 |
| cancer prevention program | 0.796838 |
| melanoma deaths | 0.381573 |
| skin cancer prevention | 0.876109 |
| overall age-adjusted melanoma | 0.439238 |
| melanoma incidence rates | 0.71846 |
| melanoma cases | 0.745118 |
| melanoma treatment costs | 0.471746 |
| United States report | 0.28129 |
| P. Guy Jr. | 0.316485 |
| Gery P. Guy | 0.318318 |
| cancer incidence statistics | 0.328736 |
| mortality data | 0.279422 |
| skin cancer screening | 0.287627 |
| melanoma death rate | 0.413625 |
| reduced melanoma incidence | 0.453032 |
| health care costs | 0.31445 |
| sun protection | 0.39468 |
| Melanoma survival | 0.367899 |
| skin cancer awareness | 0.288097 |
| melanoma incidence rate | 0.53281 |
| United States Cancer | 0.299456 |
| newly diagnosed melanoma | 0.433021 |
| Total melanoma treatment | 0.429545 |
| melanoma mortality rates | 0.422211 |
|
| higher rates | 0.298743 |
| United States | 0.659659 |
| Melanoma death rates | 0.427875 |
| skin cancer deaths | 0.352256 |
| U.S. Census Bureau | 0.300685 |
| potential melanoma cases | 0.451665 |
| Cancer mortality statistics | 0.295722 |
| Incidence count | 0.277124 |
| melanoma incidence | 0.929956 |
| higher melanoma rates | 0.407955 |
| health care | 0.38245 |
| Australian skin cancer | 0.290881 |
| melanoma reporting | 0.374076 |
| higher melanoma incidence | 0.438034 |
| comprehensive skin cancer | 0.715613 |
| current melanoma incidence | 0.467834 |
| indoor tanning | 0.312912 |
| U.S. population | 0.338237 |
| annual cost | 0.286003 |
| melanoma trends | 0.366988 |
| incidence projections | 0.281826 |
| age-adjusted melanoma incidence | 0.453415 |
| new melanoma cases | 0.526915 |
| preventive services | 0.281224 |
|
CLICK HERE |
| 16075 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Pediatric Emergency Department Visitsfor Buprenorphine/Naloxone Ingestion - United States, 2008-2015 |MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| dispensed buprenorphine/naloxone prescriptions | 0.603645 |
| pediatric medication ingestions | 0.51249 |
| multidose bottles | 0.741341 |
| traditional child-resistant bottles | 0.516205 |
| Injury Surveillance System-Cooperative | 0.572314 |
| Human Services | 0.526113 |
| Adverse Drug Event | 0.573489 |
| pediatric buprenorphine ingestions | 0.518737 |
| U.S. Department | 0.5239 |
| Drug Event Surveillance | 0.571813 |
| dispensed prescriptions | 0.520964 |
| young children | 0.544776 |
| unsupervised buprenorphine/naloxone ingestions | 0.532529 |
| product packaging/formulation changes | 0.493994 |
| National Electronic Injury | 0.572179 |
| Electronic Injury Surveillance | 0.570469 |
| Suboxone buprenorphine/naloxone tablets | 0.534665 |
| unit-dose packaged tablets | 0.611322 |
| Event Surveillance project | 0.484603 |
| child-resistant packaging | 0.498745 |
| Daniel S. Budnitz | 0.48441 |
| generic buprenorphine/naloxone products | 0.501101 |
| unit-dose packaged products | 0.57157 |
| office-based medication-assisted treatment | 0.50409 |
|
| pediatric buprenorphine/naloxone exposures | 0.521629 |
| Drug Evaluation | 0.489854 |
| Drug Administration | 0.489792 |
| Surveillance System-Cooperative Adverse | 0.573748 |
| ED visits | 0.979678 |
| opioid abuse epidemic | 0.506889 |
| generic buprenorphine/naloxone tablets | 0.533998 |
| buprenorphine/naloxone ingestions | 0.746554 |
| buprenorphine/naloxone tablets | 0.541022 |
| multidose child-resistant bottles | 0.530421 |
| pediatric buprenorphine/naloxone ingestions | 0.597908 |
| significantly lower rate | 0.486 |
| medication-assisted treatment divide | 0.486572 |
| IMS Health National | 0.50224 |
| unit-dose packaging | 0.857029 |
| national prescription audit | 0.65587 |
| pediatric ingestions | 0.506055 |
| packaging/formulation changes | 0.498604 |
| nationally representative estimates | 0.491795 |
| IMS Health | 0.645161 |
| Suboxone buprenorphine/naloxone film | 0.51171 |
| film strips | 0.492997 |
| System-Cooperative Adverse Drug | 0.573505 |
| unused partial doses | 0.485341 |
|
CLICK HERE |